Mohammed Moustapha Anwar

5PUBLICATIONS
4CO-AUTHORS
Medical infection agents (incl. prions)Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Nanoscale characterisation
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Mar 01, 2023
A peek behind the curtain in the diagnosis and management of COVID‑19‑Associated Mucormycosis (CAM).

Nermin A Osman, Mohammed Moustapha Anwar, Bivek Singh

|Dec 28, 2022
Rise of the natural red pigment 'prodigiosin' as an immunomodulator in cancer.

Mohammed Moustapha Anwar, Chris Albanese, Nadia M Hamdy

|May 31, 2022
Disengaging the COVID-19 Clutch as a Discerning Eye Over the Inflammatory Circuit During SARS-CoV-2 Infection.

Mohammed Moustapha Anwar, Ranjit Sah, Sunil Shrestha

|Sep 08, 2020
Prodigiosin/PU-H71 as a novel potential combined therapy for triple negative breast cancer (TNBC): preclinical insights.

Mohammed Moustapha Anwar, Manal Shalaby, Amira M Embaby

Pageof 1